期刊
ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 3, 期 4, 页码 496-501出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.7b00148
关键词
CpG; oligonucleotide; dendritic cell targeting; polyethylene glycol; nanoparticle vaccine; E2; biodistribution
资金
- National Institutes of Health [R21EB017995]
- National Cancer Institute of the National Institutes of Health [P30CA062203]
- University of California Cancer Research Coordinating Committee [UCCRCC-101868]
Efficient delivery of antigens is of paramount concern in immunotherapies. We aimed to target antigen presenting cells (APCs) by conjugating CpG oligonucleotides to an E2 protein nanoparticle surface (CpG-PEG-E2). Compared to E2 alone, we observed 4-fold increase of in vitro APC uptake of CpG both CpG-PEG-E2 and E2 conjugated to non-CpG DNA. Furthermore, compared to E2-alone or E2 functionalized solely with polyethylene glycol (PEG), the CpG-PEG-E2 showed enhanced lymph node retention up to at least 48 h and 2-fold increase in APC uptake in vivo, parameters which are advantageous for vaccine success. This suggests that enhanced APC uptake of nanoparticles mediated by oligonucleotide display may help overcome delivery barriers in vaccine development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据